PHV15: CLINICAL AND ECONOMIC BENEFITS OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN
Gerry Oster+4 more
openalex +1 more source
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media [PDF]
Juhani Eskola+13 more
openalex +1 more source
Pneumococcal Conjugate Vaccine Serotypes ofStreptococcus pneumoniaeIsolates and the Antimicrobial Susceptibility of Such Isolates in Children with Otitis Media [PDF]
Moses Joloba+5 more
openalex +1 more source
Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy. [PDF]
Gianella S+15 more
europepmc +1 more source
Immunogenicity of Pneumococcal Vaccine in Heart Transplant Recipients [PDF]
Emily A. Blumberg+5 more
openalex +1 more source
Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018-21. [PDF]
Schellenberg JJ+6 more
europepmc +1 more source
Limited protection of pneumococcal vaccines against emergent Streptococcus pneumoniae serotype 14/ST876 strains. [PDF]
Lan Y+15 more
europepmc +1 more source
Hospitalizations for lower respiratory tract infections in children in relation to the sequential use of three pneumococcal vaccines in Quebec. [PDF]
Zhou Z+4 more
europepmc +1 more source
Cost-Effectiveness of the Pneumococcal Vaccine in the United States Navy and Marine Corps
Patricia Vold Pepper, Douglas K Owens
openalex +1 more source
Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines [PDF]
Gabriela Echániz‐Aviles+1 more
openalex +1 more source